<DOC>
	<DOCNO>NCT00903695</DOCNO>
	<brief_summary>A vitamin nutriceutical , Memory XL , show provide maintenance cognitive status mild , moderate , severe Alzheimer 's disease patient ( 2 publication T. Shea ) . Because nutriceutical patented Univ . Mass. , trial institution may consider conflict interest . Therefore , study effect Mild Cognitive Impairment ( MCI ) patient conduct PI affiliate Univ . Mass . Dr. Shea . The study hypothesis : Memory XL maintain improve cognitive behavioral status patient diagnose MCI year participation study ; normally , 10-25 % MCI patient convert mild Alzheimer 's dementia year .</brief_summary>
	<brief_title>MemoryXL Effects Mild Cognitive Impairment Patients</brief_title>
	<detailed_description>This IRB-approved study randomize double blind study patient diagnose Mild Cognitive Impairment ( MCI ) Center Alzheimer 's Neurodegenerative Disorders ( CANDO ) VAMC Oklahoma City . Dr. Shea provide pill ( nutriceutical placebo ) batch use former study Alzheimer 's disease patient ( produce Nutricap Labs , Farmingdale , NY ) . Pills dispense OKC VAMC research pharmacist , use random number system . The PI complete five cognitive testing session , last 1 1.5 hour , subject 12 month participation study . Subject 's spouse family member complete 4 questionnaire subject 's behavioral change , keep daily record time day subject ingest study pill assign pharmacist . All subject patient VAMC memory loss clinic ( CANDO ) monitor neurologist ( 2 co-investigators study ) .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>MCI patient diagnose VAMC Center Alzheimers Neurodegenerative Disorder ( CANDO ) . Clinical Dementia Rating ( CDR ) score 0.5. fluent English . able ambulate outpatient clinic research laboratory sight hearing level sufficient complete neuropsychological testing . free bipolar disorder terminal illnesses cancer . must live spouse adult relative record nutriceutical ingestion daily . subject consecutively diagnose patient ethnic group . patient protected category prisoner pregnant woman . MCI subject develop lifethreatening disease terminal cancer , stroke , brain trauma , debilitate heart attack , etc . indication inability make decision regard study participation .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Memory XL</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>cognitive status</keyword>
</DOC>